Acadia Pharmaceuticals | Despesas Operacionais





Despesas Operacionais Alterar Data
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
ALKERMES USD 1.73B 1.44B 2025-09
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Bristol-Myers Squibb USD 18.55B 10.06B 2025-09
Corcept Therapeutics USD 197.42M 29.66M 2025-09
Cytokinetics USD 168.69M 9.58M 2025-09
Eisai JPY 183.69B 1.78B 2025-09
Eli Lilly USD 9.21B 677.8M 2025-09
Incyte USD 4.65B 3.75B 2025-09
J&J USD 18.97B 2.38B 2025-12
Moderna USD 1.28B 232M 2025-09
Neurocrine Biosciences USD 555.6M 13.7M 2025-09
Pfizer USD 92.8B 82.47B 2025-09
Prothena USD 42.18M 14.25M 2025-09
PTC Therapeutics USD 207.52M 6.21M 2025-09
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
Vertex Pharmaceuticals USD 1.84B 27.1M 2025-09


Acadia Pharmaceuticals Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.